Acetylcysteine inhalation and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Acetylcysteine inhalation and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: acetylcysteine
Brand name: Mucomyst-10, Cetylev
Synonyms: Acetylcysteine (inhalation), Acetylcysteine
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Acetylcysteine inhalation-Insulin glargine, recombinant Subcutaneous
- Acetylcysteine inhalation-Insulin glulisine
- Acetylcysteine inhalation-Insulin Glulisine (Cartridges and Pens)
- Acetylcysteine inhalation-Insulin Glulisine (Vials)
- Acetylcysteine inhalation-Insulin glulisine Subcutaneous
- Acetylcysteine inhalation-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Acetylcysteine Inhalation, oral/nebulization
- Insulin glargine and lixisenatide Subcutaneous-Acetylcysteine Injection
- Insulin glargine and lixisenatide Subcutaneous-Acetylcysteine Intravenous
- Insulin glargine and lixisenatide Subcutaneous-Acetylcysteine oral, effervescent
- Insulin glargine and lixisenatide Subcutaneous-Acetylcysteine Solution
- Insulin glargine and lixisenatide Subcutaneous-Achromycin V